Navigating bottlenecks in cell therapy manufacturing: a versatile & scalable platform solution

As cell therapies quickly advance from the preclinical stage into clinical and commercial applications, the design and implementation of scalable manufacturing platform technologies continues to be a focus of the field. Despite the successful commercialization of several cell therapies, bottlenecks in manufacturing throughput and capacity continue to hinder patient access to these life-saving treatments. This article will explore the current landscape and limitations of cell therapy manufacturing platforms and will share insights on how to choose a technology platform that assures flexibility in process development (PD) and scalability for clinical and commercial success.

Please enter your email to access content Read now